Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer

BACKGROUND: The HER family of proteins (EGFR, HER2, HER3 and HER4) have long been thought to be therapeutic targets for bladder cancer, but previous clinical trials targeting these proteins have been disappointing. Second generation agents may be more effective. OBJECTIVE: The aim of this study was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bladder Cancer
Main Authors: Tamura, Shuzo, Wang, Yin, Veeneman, Brendan, Hovelson, Daniel, Bankhead, Armand, Broses, Luke J., Lorenzatti Hiles, Guadalupe, Liebert, Monica, Rubin, John R., Day, Kathleen C., Hussain, Maha, Neamati, Nouri, Tomlins, Scott, Palmbos, Philip L., Grivas, Petros, Day, Mark L.
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2018
Assuntos:
Research Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5798519/
https://ncbi.nlm.nih.gov/pubmed/29430509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-170144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados